The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia

le Benjamin, Jonathan E., Stein, Anthony S.
Foilsithe in Ther Adv Hematol (2016)

Driving Simulator Performance in Patients with Possible and Probable Alzheimer’s Disease

le Stein, Anthony C., Dubinsky, Richard M.
Foilsithe 2011

Venetoclax-containing regimens in acute myeloid leukemia

le Aldoss, Ibrahim, Pullarkat, Vinod, Stein, Anthony S.
Foilsithe in Ther Adv Hematol (2021)

Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy

le Khaldoyanidi, Sophia, Nagorsen, Dirk, Stein, Anthony, Ossenkoppele, Gerrit, Subklewe, Marion
Foilsithe in J Clin Oncol (2021)

Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors

le Stein, Anthony S., Schiller, Gary, Benjamin, Ramsis, Jia, Catherine, Zhang, Alicia, Zhu, Min, Zimmerman, Zachary, Topp, Max S.
Foilsithe in Ann Hematol (2018)

Improved Outcomes Using Tacrolimus/Sirolimus for Graft Versus Host Disease prophylaxis with a Reduced Intensity Conditioning Regimen for Allogeneic Hematopoietic Cell Transplant as...

le Snyder, David S., Palmer, Joycelynne, Gaal, Karl, Stein, Anthony S., Pullarkat, Vinod, Sahebi, Firoozeh, Vora, Nyana, Nakamura, Ryotaro, Forman, Stephen J.
Foilsithe 2009

Phase 1/2 trial of total marrow and lymph node irradiation to augment reduced-intensity transplantation for advanced hematologic malignancies

le Rosenthal, Joseph, Wong, Jeffrey, Stein, Anthony, Qian, Dajun, Hitt, Debbie, Naeem, Hossameldin, Dagis, Andrew, Thomas, Sandra H., Forman, Stephen
Foilsithe 2011

Dose Escalation of Total Marrow Irradiation with Concurrent Chemotherapy in Patients with Advanced Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

le Wong, Jeffrey Y.C., Forman, Stephen, Somlo, George, Rosenthal, Joseph, Liu, An, Schultheiss, Timothy, Radany, Eric, Palmer, Joycelynne, Stein, Anthony
Foilsithe in Int J Radiat Oncol Biol Phys (2012)

First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases

le Sun, Weili, Liu, Huaying, Kim, Young, Karras, Nicole, Pawlowska, Anna, Toomey, Debbie, Kyono, Wade, Gaynon, Paul, Rosenthal, Joseph, Stein, Anthony
Foilsithe in J Hematol Oncol (2018)

Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells

le Cook, Amy M., Li, Liang, Ho, Yinwei, Lin, Allen, Li, Ling, Stein, Anthony, Forman, Stephen, Perrotti, Danilo, Jove, Richard, Bhatia, Ravi
Foilsithe 2014

Health-related quality of life in adults with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab

le Topp, Max S., Zimmerman, Zachary, Cannell, Paul, Dombret, Hervé, Maertens, Johan, Stein, Anthony, Franklin, Janet, Tran, Qui, Cong, Ze, Schuh, Andre C.
Foilsithe in Blood (2018)

Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia

le Stein, Anthony S., Larson, Richard A., Schuh, Andre C., Stevenson, William, Lech-Maranda, Ewa, Tran, Qui, Zimmerman, Zachary, Kormany, William, Topp, Max S.
Foilsithe in Blood Adv (2018)

Blinatumomab as first salvage versus second or later salvage in adults with relapsed/refractory B‐cell precursor acute lymphoblastic leukemia: Results of a pooled analysis

le Topp, Max S., Stein, Anthony S., Gökbuget, Nicola, Horst, Heinz‐August, Boissel, Nicolas, Martinelli, Giovanni, Kantarjian, Hagop, Brüggemann, Monika, Chen, Yuqi, Zugmaier, Gerhard
Foilsithe in Cancer Med (2021)

Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

le Stein, Anthony, Franklin, Janet L., Chia, Victoria M., Arrindell, Deborah, Kormany, William, Wright, Jacqueline, Parson, Mandy, Amouzadeh, Hamid R., Choudhry, Jessica, Joseph, Guiandre
Foilsithe in Drug Saf (2018)

Venetoclax and hypomethylating agents in TP53-mutated acute myeloid leukaemia

le Aldoss, Ibrahim, Zhang, Jianying, Pillai, Raju, Shouse, Geoff, Sanchez, James F, Mei, Matthew, Nakamura, Ryotaro, Stein, Anthony S, Forman, Stephen J, Marcucci, Guido, Pullarkat, Vinod
Foilsithe in Br J Haematol (2019)

Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome–positive B‐precursor acute lymphoblastic leukemia...

le Rambaldi, Alessandro, Ribera, Josep‐Maria, Kantarjian, Hagop M., Dombret, Hervé, Ottmann, Oliver G., Stein, Anthony S., Tuglus, Catherine A., Zhao, Xiaoyue, Kim, Christopher, Martinelli, Giovanni
Foilsithe in Cancer (2019)

Long‐term survival of patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab

le Topp, Max S., Gökbuget, Nicola, Zugmaier, Gerhard, Stein, Anthony S., Dombret, Hervé, Chen, Yuqi, Ribera, Josep‐Maria, Bargou, Ralf C., Horst, Heinz‐August, Kantarjian, Hagop M.
Foilsithe in Cancer (2020)

Exosome-driven lipolysis and bone marrow niche remodeling support leukemia expansion

le Kumar, Bijender, Orellana, Marvin, Brooks, Jamison, Madabushi, Srideshikan Sargur, Vishwasrao, Paresh, Parra, Liliana E., Sanchez, James, Salhotra, Amandeep, Stein, Anthony, Chen, Ching-Cheng, Marcucci, Guido, Hui, Susanta Kumar
Foilsithe in Haematologica (2020)

Reduced intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia

le Stein, Anthony S., Palmer, Joycelynne M., O'Donnell, Margaret R., Kogut, Neil M., Spielberger, Ricardo T., Slovak, Marilyn L., Tsai, Ni-Chun, Senitzer, David, Snyder, David S., Thomas, Sandra H., J.Forman, Stephen
Foilsithe 2009

Targeting MCL-1 in Hematologic Malignancies: Rationale and Progress

le Wei, Andrew H., Roberts, Andrew W., Spencer, Andrew, Rosenberg, Aaron Seth, Siegel, David, Walter, Roland B., Caenepeel, Sean, Hughes, Paul, McIver, Zach, Mezzi, Khalid, Morrow, Phuong Khanh, Stein, Anthony
Foilsithe in Blood Rev (2020)